Follow Us      


   Offical Journal of The Academy of Osseointegration

Share Page:

Volume 39 , Issue 3
May/June 2019

Pages 361–368

Clinical Guidelines for Implant Treatment in Patients with Down Syndrome

Hugo De Bruyn, DDS, MSc, PhD/Maarten Glibert, DDS, MSc/Liesbet Matthijs, DDS, MSc/Martens Filip, DDS, MSc/Véronique Christiaens, DDS, MSc/Luc Marks, DDS, MSc, PhD

PMID: 29590223
DOI: 10.11607/prd.3284

This study evaluated implant outcome in patients with Down syndrome (DSPs) and provides clinical guidelines to maximize treatment outcome. A total of 57 implants were placed in eight DSPs. During follow-up, implant survival was recorded and crestal bone level was evaluated when possible. After a mean follow-up time of 5 years, six patients with 45 implants were evaluated and an implant survival rate of 84.4% was recorded. A mean crestal bone loss of 1.7 mm (SD 0.9) was measured in three patients around 20 implants. Down syndrome is not a contraindication to dental implant placement, but multiple complicating factors yield reduced implant survival.

Full Text PDF File | Order Article


Get Adobe Reader
Adobe Acrobat Reader is required to view PDF files. This is a free program available from the Adobe web site.
Follow the download directions on the Adobe web site to get your copy of Adobe Acrobat Reader.


© 2020 Quintessence Publishing Co, Inc

PRD Home
Current Issue
Ahead of Print
Author Guidelines
Submission Form
Quintessence Home
Terms of Use
Privacy Policy
About Us
Contact Us